• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“未另行规定的腺癌”:一组逐渐减少的唾液腺癌。

"Adenocarcinoma, not otherwise specified": a diminishing group of salivary carcinomas.

作者信息

Batsakis J G, el-Naggar A K, Luna M A

机构信息

Dept of Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

出版信息

Ann Otol Rhinol Laryngol. 1992 Jan;101(1):102-4. doi: 10.1177/000348949210100123.

DOI:10.1177/000348949210100123
PMID:1728879
Abstract

As refinements in classification with clinicopathologic correlations proceed, the "adenocarcinomas, not otherwise specified" (NOS) of salivary tissue are reduced in number. Clinicopathologic entities such as salivary duct carcinoma, terminal duct carcinoma, and epimyoepithelial carcinoma, formerly in the NOS category, are examples of this process. There remain, however, adenocarcinomas of salivary tissues that cannot be accommodated in conventional classifications. They are the least common of salivary carcinomas and manifest a cytoarchitecture ranging from a well-differentiated, low-grade appearance to high-grade, invasive lesions. This report addresses this group of carcinomas for which the NOS designation is still applicable.

摘要

随着伴有临床病理相关性的分类方法不断完善,唾液腺组织中“未另行规定的腺癌”(NOS)数量减少。诸如唾液腺导管癌、终末导管癌和肌上皮癌等临床病理实体,以前属于NOS类别,就是这一过程的例证。然而,仍存在一些唾液腺组织腺癌无法纳入传统分类。它们是唾液腺癌中最不常见的类型,其细胞结构从高分化、低级别表现到高级别浸润性病变不等。本报告探讨了这一组仍适用NOS命名的癌。

相似文献

1
"Adenocarcinoma, not otherwise specified": a diminishing group of salivary carcinomas.“未另行规定的腺癌”:一组逐渐减少的唾液腺癌。
Ann Otol Rhinol Laryngol. 1992 Jan;101(1):102-4. doi: 10.1177/000348949210100123.
2
Salivary gland adenocarcinomas: a clinicopathologic analysis of three distinctive types.唾液腺癌:三种独特类型的临床病理分析
Semin Diagn Pathol. 1987 May;4(2):117-35.
3
The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria.未特指为肿瘤实体的唾液腺癌的衰退:使用当代免疫组织化学特征分析和诊断标准进行重新分类。
Am J Surg Pathol. 2021 Jun 1;45(6):753-764. doi: 10.1097/PAS.0000000000001636.
4
Low-grade and high-grade adenocarcinomas of the salivary duct system.涎腺导管系统的低级别和高级别腺癌。
Ann Otol Rhinol Laryngol. 1989 Feb;98(2):162-3. doi: 10.1177/000348948909800216.
5
Terminal duct adenocarcinomas of salivary tissues.涎腺组织终末导管腺癌
Ann Otol Rhinol Laryngol. 1991 Mar;100(3):251-3. doi: 10.1177/000348949110000316.
6
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.唾液腺癌中的人表皮生长因子受体 2(HER2)。
Pathology. 2011 Aug;43(5):459-64. doi: 10.1097/PAT.0b013e3283484a60.
7
Unusual salivary glands adenocarcinomas: a retrospective study.罕见唾液腺癌:一项回顾性研究。
J Exp Clin Cancer Res. 2001 Jun;20(2):189-94.
8
Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas.口腔腺癌:终末导管癌的临床病理研究
J Laryngol Otol. 1983 Sep;97(9):825-35. doi: 10.1017/s0022215100095062.
9
[Clinicopathological study of salivary gland adenocarcinomas].唾液腺癌的临床病理研究
Nihon Jibiinkoka Gakkai Kaiho. 1989 Dec;92(12):2047-54. doi: 10.3950/jibiinkoka.92.2047.
10
Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.唾液腺肿瘤中的前列腺标志物免疫反应性。免疫组织化学中一个罕见的陷阱。
Am J Surg Pathol. 1993 Apr;17(4):410-4. doi: 10.1097/00000478-199304000-00012.

引用本文的文献

1
Brain metastases in patients with salivary duct carcinoma: A retrospective study.涎腺癌脑转移患者:一项回顾性研究。
Cancer Med. 2024 Mar;13(5):e7037. doi: 10.1002/cam4.7037.
2
Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers.涎腺癌预后因素的组织病理学方面
Cancers (Basel). 2023 Feb 15;15(4):1236. doi: 10.3390/cancers15041236.
3
Intraoral Pigmented Low-Grade Adenocarcinoma, Not Otherwise Specified: Case Report and Immunohistochemical Study.口腔内色素沉着性低级别腺癌,未另行分类:病例报告及免疫组织化学研究
Head Neck Pathol. 2018 Dec;12(4):610-618. doi: 10.1007/s12105-017-0875-1. Epub 2017 Dec 22.
4
Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.雄激素受体、HER2、Ki-67和EGFR表达在涎腺导管癌中的临床病理意义
Int J Clin Oncol. 2015 Feb;20(1):35-44. doi: 10.1007/s10147-014-0674-6. Epub 2014 Feb 20.
5
P27/SKP-2 histochemical profile is relevant to malignant salivary gland tumors (MST) histogenesis and tumor grade.P27/SKP - 2组织化学特征与恶性涎腺肿瘤(MST)的组织发生及肿瘤分级相关。
Head Neck Pathol. 2012 Jun;6(2):157-65. doi: 10.1007/s12105-011-0309-4. Epub 2011 Nov 18.
6
The buccal minor salivary glands as starting point for a metastasizing adenocarcinoma--report of a case.以颊部小唾液腺作为转移性腺癌的起始部位——1例报告
Head Face Med. 2008 Jul 30;4:16. doi: 10.1186/1746-160X-4-16.
7
Preinvasive intraductal neoplasia in salivary adenocarcinoma, not otherwise specified.唾液腺癌中未另行规定的浸润前导管内瘤变。
Virchows Arch. 2006 Aug;449(2):159-63. doi: 10.1007/s00428-006-0208-3. Epub 2006 May 4.